EyePoint (EYPT) Accumulated Expenses (2011 - 2026)
EyePoint (EYPT) reported Accumulated Expenses of $6.7 million for Q1 2026, down 63.24% on a YoY basis from $18.2 million in Q1 2025, and down 72.6% sequentially from $24.4 million in Q4 2025.
EyePoint (EYPT) Accumulated Expenses (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Accumulated Expenses data on file, last reported at $6.7 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 63.24% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 63.24% YoY), and the FY2025 full-year result was $24.4 million, up 34.75% from the prior year.
- Accumulated Expenses eased to $6.7 million in Q1 2026, from $24.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $24.4 million in Q4 2025 to a low of $3.1 million in Q1 2022.
- A 5-year average of $12.3 million and a median of $13.3 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses jumped 274.71% in 2024 and sank 63.24% in 2026, its largest moves.
- Tracing EYPT's Accumulated Expenses over 5 years: stood at $16.4 million in 2022, then dropped by 22.79% to $12.6 million in 2023, then jumped by 43.32% to $18.1 million in 2024, then soared by 34.75% to $24.4 million in 2025, then slumped by 72.6% to $6.7 million in 2026.
- Business Quant data shows EYPT's Accumulated Expenses at $6.7 million in Q1 2026, $24.4 million in Q4 2025, and $10.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.68 Mn |
| Dec 31, 2025 | 24.39 Mn |
| Sep 30, 2025 | 10.93 Mn |
| Jun 30, 2025 | 11.48 Mn |
| Mar 31, 2025 | 18.18 Mn |
| Dec 31, 2024 | 18.10 Mn |
| Sep 30, 2024 | 14.17 Mn |
| Jun 30, 2024 | 13.34 Mn |
| Mar 31, 2024 | 15.94 Mn |
| Dec 31, 2023 | 12.63 Mn |
| Sep 30, 2023 | 13.42 Mn |
| Jun 30, 2023 | 15.15 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 6.55 Mn |
| Jun 30, 2022 | 4.88 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | 11.46 Mn |
| Jun 30, 2021 | 3.46 Mn |